- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06170788
PD-L1 종양 비율 점수(TPS) ≥ 50%인 전이성 비소세포폐암(NSCLC)에서 MK-2870과 펨브롤리주맙 병용 요법(MK-2870-007) (TroFuse-007)
PD-L1 TPS가 50% 이상인 전이성 비소세포폐암 참가자의 1차 치료에서 펨브롤리주맙 단독요법과 비교한 MK-2870과 펨브롤리주맙의 무작위 공개 라벨 제3상 연구
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS). The primary hypothesis is that the combination of sacituzumab tirumotecan and pembrolizumab is superior to pembrolizumab alone with respect to OS.
연구 개요
상태
연구 유형
등록 (추정된)
단계
- 3단계
연락처 및 위치
연구 연락처
- 이름: Toll Free Number
- 전화번호: 1-888-577-8839
- 이메일: Trialsites@msd.com
연구 장소
-
-
North Brabant
-
Breda, North Brabant, 네덜란드, 4818 CK
- 모병
- Amphia Ziekenhuis, locatie Breda Molengracht-long oncologie ( Site 1901)
-
연락하다:
- Study Coordinator
- 전화번호: 0031765955349
-
Tilburg, North Brabant, 네덜란드, 5022 GC
- 모병
- ETZ Elisabeth-Department of Pulmonary Diseases ( Site 1902)
-
연락하다:
- Study Coordinator
- 전화번호: 0031132213101
-
-
Overijssel
-
Zwolle, Overijssel, 네덜란드, 8025 AB
- 모병
- Isala, locatie Zwolle-Poli Longziekten ( Site 1903)
-
연락하다:
- Study Coordinator
- 전화번호: 0031886243254
-
-
-
-
-
Hsinchu, 대만, 300
- 모병
- National Taiwan University Hospital - Hsinchu branch ( Site 3901)
-
연락하다:
- Study Coordinator
- 전화번호: +886-972-651-703
-
Kaohsiung City, 대만, 83301
- 모병
- Chang Gung Memorial Hospital at Kaohsiung ( Site 3902)
-
연락하다:
- Study Coordinator
- 전화번호: 88677317123
-
Kaohsiung City, 대만, 807
- 완전한
- Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 3904)
-
New Taipei City, 대만, 23561
- 모병
- Taipei Medical University Shuang Ho Hospital ( Site 3912)
-
연락하다:
- Study Coordinator
- 전화번호: +886970746943
-
Taichung, 대만, 40705
- 완전한
- Taichung Veterans General Hospital-Chest ( Site 3905)
-
Tainan, 대만, 704
- 모병
- National Cheng Kung University Hospital-Clinical Trial Center ( Site 3903)
-
연락하다:
- Study Coordinator
- 전화번호: 88662353535
-
Tainan, 대만, 71004
- 모병
- Chi Mei Medical Center ( Site 3915)
-
연락하다:
- Study Coordinator
- 전화번호: +886980195306
-
Taipei, 대만, 10449
- 모병
- Mackay Memorial Hospital ( Site 3909)
-
연락하다:
- Study Coordinator
- 전화번호: +886975835146
-
Taipei, 대만, 10002
- 완전한
- National Taiwan University Hospital-Oncology ( Site 3906)
-
-
Tainan
-
Tainan, Tainan, 대만, 73657
- 모병
- Chi Mei Hospital - Liouying Branch ( Site 3908)
-
연락하다:
- Study Coordinator
- 전화번호: +886963051211
-
-
Taipei
-
Taipei City, Taipei, 대만, 106
- 모병
- National Taiwan University Cancer Center (NTUCC) ( Site 3907)
-
연락하다:
- Study Coordinator
- 전화번호: +886223123456x267511
-
-
-
-
-
Seoul, 대한민국, 05505
- 모병
- Asan Medical Center-Lung Cancer Center ( Site 3805)
-
연락하다:
- Study Coordinator
- 전화번호: 02-3010-5419
-
Seoul, 대한민국, 06351
- 모병
- Samsung Medical Center-Division of Hematology/Oncology ( Site 3802)
-
연락하다:
- Study Coordinator
- 전화번호: 82-2-3410-3453
-
-
Kang-won-do
-
Wŏnju, Kang-won-do, 대한민국, 26426
- 완전한
- Wonju Severance Christian Hospital ( Site 3808)
-
-
Kyonggi-do
-
Goyang-si, Kyonggi-do, 대한민국, 10408
- 모병
- National Cancer Center ( Site 3801)
-
연락하다:
- Study Coordinator
- 전화번호: +82319200406
-
Suwon, Kyonggi-do, 대한민국, 16247
- 모병
- The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3800)
-
연락하다:
- Study Coordinator
- 전화번호: 82-31-249-7744
-
Suwon, Kyonggi-do, 대한민국, 16499
- 완전한
- Ajou University Hospital-Hematology-Oncology ( Site 3806)
-
-
North Chungcheong
-
Cheongju-si, North Chungcheong, 대한민국, 28644
- 모병
- Chungbuk National University Hospital-Internal medicine ( Site 3804)
-
연락하다:
- Study Coordinator
- 전화번호: 82-43-269-6015
-
-
Taegu-Kwangyokshi
-
Daegu, Taegu-Kwangyokshi, 대한민국, 42601
- 모병
- Keimyung University Dongsan Hospital CRC room 1 ( Site 3807)
-
연락하다:
- Study Coordinator
- 전화번호: 82532586671
-
-
-
-
Central Jutland
-
Herning, Central Jutland, 덴마크, 7400
- 모병
- Regionshospitalet Gødstrup-Kræftklinikken ( Site 1204)
-
연락하다:
- Study Coordinator
- 전화번호: +45 78430453
-
-
North Denmark
-
Aalborg, North Denmark, 덴마크, 9000
- 모병
- Aalborg Universitetshospital, Syd-Department of Oncology ( Site 1201)
-
연락하다:
- Study Coordinator
- 전화번호: +45 97660000
-
-
Region Syddanmark
-
Odense C, Region Syddanmark, 덴마크, 5000
- 모병
- Odense Universitetshospital ( Site 1200)
-
연락하다:
- Study Coordinator
- 전화번호: +4523612809
-
-
-
-
-
Berlin, 독일, 13353
- 모병
- Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 1402)
-
연락하다:
- Study Coordinator
- 전화번호: +4930450553044
-
-
Bavaria
-
München, Bavaria, 독일, 81925
- 모병
- Klinikum Bogenhausen-Klinik für Pneumologie und Onkologische Pneumologie ( Site 1406)
-
연락하다:
- Study Coordinator
- 전화번호: 0049892704316
-
München, Bavaria, 독일, 80336
- 완전한
- Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Medizinische Klinik V ( Site 1409)
-
Nuremberg, Bavaria, 독일, 90419
- 완전한
- Klinikum Nürnberg Nord-5. Med. Klinik ( Site 1407)
-
-
Hesse
-
Marburg, Hesse, 독일, 35043
- 모병
- Universitätsklinikum Marburg-Comprehensive Cancer Center ( Site 1412)
-
연락하다:
- Study Coordinator
- 전화번호: +4964215861819
-
-
Lower Saxony
-
Hanover, Lower Saxony, 독일, 30625
- 모병
- Medizinische Hochschule Hannover-Department of Pneumology ( Site 1411)
-
연락하다:
- Study Coordinator
- 전화번호: 49 511 532 6553
-
-
North Rhine-Westphalia
-
Moers, North Rhine-Westphalia, 독일, 47441
- 모병
- Bethanien Krankenhaus Moers ( Site 1400)
-
연락하다:
- Study Coordinator
- 전화번호: +49 2841 200 2297
-
Münster, North Rhine-Westphalia, 독일, 48149
- 모병
- Universitätsklinikum Münster - Albert Schweitzer Campus-Medizinische Klinik A ( Site 1410)
-
연락하다:
- Study Coordinator
- 전화번호: +49 251 83-52712
-
-
Rhineland-Palatinate
-
Mainz, Rhineland-Palatinate, 독일, 55131
- 모병
- Universitätsmedizin Johannes Gutenberg Universität Mainz- Klinik für Pneumologie ( Site 1404)
-
연락하다:
- Study Coordinator
- 전화번호: +496131177031
-
-
Schleswig-Holstein
-
Großhansdorf, Schleswig-Holstein, 독일, 22927
- 모병
- LungenClinic Grosshansdorf-Onkologie ( Site 1401)
-
연락하다:
- Study Coordinator
- 전화번호: +49 4102 6012421
-
-
Thuringia
-
Gera, Thuringia, 독일, 07548
- 모병
- SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1403)
-
연락하다:
- Study Coordinator
- 전화번호: 00493658287758
-
-
-
-
-
Oaxaca City, 멕시코, 68000
- 모병
- Oaxaca Site Management Organization S.C. ( Site 0718)
-
연락하다:
- Study Coordinator
- 전화번호: +529511301554
-
Puebla City, 멕시코, 72530
- 모병
- Clinica Integral Internacional de Oncología ( Site 0714)
-
연락하다:
- Study Coordinator
- 전화번호: +522223555576
-
-
Jalisco
-
Guadalajara, Jalisco, 멕시코, 44630
- 모병
- CIO - Centro de Inmuno-Oncología de Occidente ( Site 0715)
-
연락하다:
- Study Coordinator
- 전화번호: 3330447001
-
-
Mexico City
-
Mexico City, Mexico City, 멕시코, 11819
- 모병
- Higiea Oncologia ( Site 0721)
-
연락하다:
- Study Coordinator
- 전화번호: 5552731712
-
-
Nuevo León
-
Monterrey, Nuevo León, 멕시코, 64060
- 완전한
- Axis Heilsa S. de R.L. de C.V. ( Site 0719)
-
-
San Luis Potosí
-
San Luis Potosí City, San Luis Potosí, 멕시코, 78200
- 모병
- Centro de Atención e Investigación Cardiovascular del Potosí ( Site 0713)
-
연락하다:
- Study Coordinator
- 전화번호: +52 444 585 2263
-
-
-
-
Arizona
-
Phoenix, Arizona, 미국, 85054
- 모병
- Mayo Clinic in Arizona - Phoenix ( Site 0147)
-
연락하다:
- Study Coordinator
- 전화번호: 480-342-4800
-
-
California
-
Burbank, California, 미국, 91505
- 모병
- Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0130)
-
연락하다:
- Study Coordinator
- 전화번호: 818-840-0921
-
-
Colorado
-
Grand Junction, Colorado, 미국, 81501
- 모병
- Cancer Centers of Colorado St. Mary's Regional Hospital ( Site 0132)
-
연락하다:
- Study Coordinator
- 전화번호: 970-298-7638
-
-
Florida
-
Jacksonville, Florida, 미국, 32224
- 모병
- Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0133)
-
연락하다:
- Study Coordinator
- 전화번호: 904-953-9945
-
-
Georgia
-
Marietta, Georgia, 미국, 30060
- 완전한
- Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0106)
-
-
Kentucky
-
Louisville, Kentucky, 미국, 40202
- 완전한
- The University of Louisville, James Graham Brown Cancer Center ( Site 0121)
-
-
Maine
-
Westbrook, Maine, 미국, 04092
- 모병
- New England Cancer Specialists ( Site 0143)
-
연락하다:
- Study Coordinator
- 전화번호: 207-303-3424
-
-
Massachusetts
-
Worcester, Massachusetts, 미국, 01655
- 완전한
- University of Massachusetts Chan Medical School-Division of Hematology/Oncology ( Site 0144)
-
-
Minnesota
-
Minneapolis, Minnesota, 미국, 55407
- 모병
- Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0115)
-
연락하다:
- Study Coordinator
- 전화번호: 651-241-7025
-
Rochester, Minnesota, 미국, 55905
- 모병
- Mayo Clinic - Rochester ( Site 0148)
-
연락하다:
- Study Coordinator
- 전화번호: 507-538-1665
-
-
Mississippi
-
Hattiesburg, Mississippi, 미국, 39401
- 모병
- Hattiesburg Clinic Hematology/Oncology ( Site 0104)
-
연락하다:
- Study Coordinator
- 전화번호: 601-261-1700
-
-
Nevada
-
Reno, Nevada, 미국, 89502
- 모병
- Renown Regional Medical Center-Renown Health Medical Oncology ( Site 0134)
-
연락하다:
- Study Coordinator
- 전화번호: 775-982-5050
-
-
Ohio
-
Cleveland, Ohio, 미국, 44106
- 완전한
- University Hospitals Cleveland Medical Center ( Site 0119)
-
-
Oregon
-
Corvallis, Oregon, 미국, 97330
- 모병
- Good Samaritan Regional Medical Center-Samaritan Pastega Regional Cancer Center ( Site 0117)
-
연락하다:
- Study Coordinator
- 전화번호: 541-768-4950
-
-
Texas
-
Houston, Texas, 미국, 77030
- 완전한
- Oncology Consultants P.A. ( Site 0129)
-
-
-
-
-
Ho Chi Minh City, 베트남, 700000
- 모집하지 않고 적극적으로
- Thong Nhat Hospital ( Site 4170)
-
Ho Chi Minh City, 베트남, 700000
- 모집하지 않고 적극적으로
- Ho Chi Minh City Oncology Hospital - Tan Phu Ward ( Site 4173)
-
Hà Nội, 베트남, 100000
- 모집하지 않고 적극적으로
- K Hospital - National Cancer Hospital ( Site 4174)
-
-
Hanoi
-
Hanoi, Hanoi, 베트남, 100000
- 모집하지 않고 적극적으로
- National Lung Hospital-Oncology Department ( Site 4175)
-
Hanoi, Hanoi, 베트남, 100000
- 모집하지 않고 적극적으로
- Tam Anh General Hospital ( Site 4179)
-
Ho Chi Minh, Hanoi, 베트남, 700000
- 모집하지 않고 적극적으로
- Cho Ray Hospital ( Site 4171)
-
-
-
-
-
Rio de Janeiro, 브라질, 20230-130
- 모병
- Instituto Nacional de Câncer - INCA ( Site 0405)
-
연락하다:
- Study Coordinator
- 전화번호: +552132076564
-
São Paulo, 브라질, 04014-012
- 모병
- Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0401)
-
연락하다:
- Study Coordinator
- 전화번호: +551144500300
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, 브라질, 90020-090
- 모병
- Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0409)
-
연락하다:
- Study Coordinator
- 전화번호: +55 51 3214 8151
-
Santa Maria, Rio Grande do Sul, 브라질, 97015-450
- 모집하지 않고 적극적으로
- Clinica Viver ( Site 0400)
-
-
São Paulo
-
Barretos, São Paulo, 브라질, 14784400
- 모병
- Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0402)
-
연락하다:
- Study Coordinator
- 전화번호: +551733216637
-
São José do Rio Preto, São Paulo, 브라질, 15090000
- 모병
- Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0406)
-
연락하다:
- Study Coordinator
- 전화번호: +551732015054
-
-
-
-
-
Barcelona, 스페인, 08035
- 모병
- Hospital Universitari Vall d'Hebron-Oncology ( Site 2330)
-
연락하다:
- Study Coordinator
- 전화번호: +34932746000
-
Madrid, 스페인, 28006
- 모병
- Hospital La Princesa ( Site 2338)
-
연락하다:
- Study Coordinator
- 전화번호: +34915202200
-
Santa Cruz de Tenerife, 스페인, 38010
- 모병
- Hospital Universitario Nuestra Senora de la Candelaria ( Site 2339)
-
연락하다:
- Study Coordinator
- 전화번호: 922602020
-
Seville, 스페인, 41013
- 모병
- HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 2337)
-
연락하다:
- Study Coordinator
- 전화번호: +34955013068
-
-
Cadiz
-
Jerez de la Frontera, Cadiz, 스페인, 11407
- 모병
- Hospital Jerez de la Frontera-UGC Oncología ( Site 2333)
-
연락하다:
- Study Coordinator
- 전화번호: +3485681420
-
-
La Coruna
-
A Coruña, La Coruna, 스페인, 15006
- 모병
- CHUAC-Hospital Teresa Herrera-MEDICAL ONCOLOGY ( Site 2335)
-
연락하다:
- Study Coordinator
- 전화번호: 34981178000x292872
-
-
Madrid
-
Pozuelo de Alarcón, Madrid, 스페인, 28223
- 모병
- HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2331)
-
연락하다:
- Study Coordinator
- 전화번호: +34914521987
-
-
Malaga
-
Málaga, Malaga, 스페인, 29011
- 모병
- H.R.U Malaga - Hospital General ( Site 2332)
-
연락하다:
- Study Coordinator
- 전화번호: +34 95 130 81 30
-
-
Valenciana, Comunitat
-
Valencia, Valenciana, Comunitat, 스페인, 46009
- 모병
- Fundación Instituto Valenciano de Oncología-Oncologico ( Site 2336)
-
연락하다:
- Study Coordinator
- 전화번호: +34961114229
-
-
-
-
-
Buenos Aires, 아르헨티나, C1118AAT
- 모병
- Hospital Aleman-Oncology ( Site 0300)
-
연락하다:
- Study Coordinator
- 전화번호: +541148277000
-
-
Buenos Aires
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, 아르헨티나, C1426ANZ
- 모병
- Instituto Alexander Fleming ( Site 0306)
-
연락하다:
- Study Coordinator
- 전화번호: +54 9 011-3221-8900
-
-
Buenos Aires F.D.
-
Buenos Aires, Buenos Aires F.D., 아르헨티나, C1280AEB
- 모병
- Hospital Británico de Buenos Aires-Oncology ( Site 0304)
-
연락하다:
- Study Coordinator
- 전화번호: +541143096807
-
-
Córdoba Province
-
Río Cuarto, Córdoba Province, 아르헨티나, X5800ALB
- 모병
- Centro Privado de RMI Río Cuarto S.A. II ( Site 0310)
-
연락하다:
- Study Coordinator
- 전화번호: +54351153819050
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, 아르헨티나, S2000KZE
- 모병
- Instituto de Oncología de Rosario ( Site 0301)
-
연락하다:
- Study Coordinator
- 전화번호: +549-341-5778394
-
-
-
-
England
-
London, England, 영국, NW3 2QG
- 모집하지 않고 적극적으로
- Royal Free Hospital ( Site 2601)
-
-
Hampshire
-
Portsmouth, Hampshire, 영국, PO6 3LY
- 모병
- Queen Alexandra Hospital-Oncology Department ( Site 2603)
-
연락하다:
- Study Coordinator
- 전화번호: 023 9228 6000 x4078
-
-
Kent
-
Canterbury, Kent, 영국, CT1 3NG
- 모병
- Kent and Canterbury Hospital-Oncology Research ( Site 2606)
-
연락하다:
- Study Coordinator
- 전화번호: 01227 866393
-
-
London, City of
-
London, London, City of, 영국, SE1 9RT
- 모집하지 않고 적극적으로
- Guy's & St Thomas' NHS Foundation Trust-Oncology & Haematology Clinical Trials ( Site 2605)
-
-
Middlesbrough
-
Central Middlesbrough, Middlesbrough, 영국, TS4 3BW
- 모집하지 않고 적극적으로
- James Cook University Hospital ( Site 2604)
-
-
-
-
-
Bergamo, 이탈리아, 24127
- 모병
- Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII ( Site 1810)
-
연락하다:
- Study Coordinator
- 전화번호: +390352673687
-
Catanzaro, 이탈리아, 88100
- 모병
- AOU Renato Dulbecco ( Site 1801)
-
연락하다:
- Study Coordinator
- 전화번호: +390961883221
-
Florence, 이탈리아, 50134
- 모병
- Azienda Ospedaliera Universitaria Careggi ( Site 1809)
-
연락하다:
- Study Coordinator
- 전화번호: +390557947298
-
Roma, 이탈리아, 00168
- 모병
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1806)
-
연락하다:
- Study Coordinator
- 전화번호: +390630154844
-
-
Apulia
-
Bari, Apulia, 이탈리아, 70124
- 모병
- Instituto Tumori Giovanni Paolo II-SSD Oncologia Medica per la Patologia Toracica ( Site 1804)
-
연락하다:
- Study Coordinator
- 전화번호: +390805555442
-
-
Emilia-Romagna
-
Meldola, Emilia-Romagna, 이탈리아, 47014
- 모병
- IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 1807)
-
연락하다:
- Study Coordinator
- 전화번호: +390543739100
-
-
Friuli Venezia Giulia
-
Udine, Friuli Venezia Giulia, 이탈리아, 33100
- 모병
- P.O. "S. Maria della Misericordia" Azienda Sanitaria Univers-Oncology Department ( Site 1803)
-
연락하다:
- Study Coordinator
- 전화번호: +390432552751
-
-
Lombardy
-
Milan, Lombardy, 이탈리아, 20133
- 모병
- Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1800)
-
연락하다:
- Study Coordinator
- 전화번호: +390223903813
-
-
-
-
-
Fukuoka, 일본, 810-8563
- 모집하지 않고 적극적으로
- National Hospital Organization Kyushu Medical Center ( Site 3416)
-
Kumamoto, 일본, 861-4193
- 모병
- Saiseikai Kumamoto Hospital ( Site 3419)
-
연락하다:
- Study Coordinator
- 전화번호: +81-96-351-8000
-
Osaka, 일본, 541-8567
- 모병
- Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 3414)
-
연락하다:
- Study Coordinator
- 전화번호: +81-6-6945-1181
-
-
Aichi-ken
-
Toyoake, Aichi-ken, 일본, 470-1192
- 모병
- Fujita Health University Hospital ( Site 3411)
-
연락하다:
- Study Coordinator
- 전화번호: +81-562-93-2111
-
-
Aomori
-
Hirosaki, Aomori, 일본, 036-8563
- 모집하지 않고 적극적으로
- Hirosaki University Hospital ( Site 3429)
-
-
Chiba
-
Kashiwa, Chiba, 일본, 277-8577
- 모병
- National Cancer Center Hospital East ( Site 3403)
-
연락하다:
- Study Coordinator
- 전화번호: +81-4-7133-1111
-
-
Ehime
-
Matsuyama, Ehime, 일본, 791-0280
- 모병
- National Hospital Organization Shikoku Cancer Center ( Site 3415)
-
연락하다:
- Study Coordinator
- 전화번호: +81-89-999-1111
-
-
Fukuoka
-
Fukuoka, Fukuoka, 일본, 811-1395
- 모병
- National Hospital Organization Kyushu Cancer Center ( Site 3417)
-
연락하다:
- Study Coordinator
- 전화번호: +81-92-541-3231
-
Kurume, Fukuoka, 일본, 830-0011
- 모병
- Kurume University Hospital ( Site 3418)
-
연락하다:
- Study Coordinator
- 전화번호: +81-942-35-3311
-
-
Gunma
-
Ōta, Gunma, 일본, 373-8550
- 모병
- Gunma Prefectural Cancer Center ( Site 3402)
-
연락하다:
- Study Coordinator
- 전화번호: +81-276-38-0771
-
-
Hyōgo
-
Himeji, Hyōgo, 일본, 670-8520
- 모병
- National Hospital Organization Himeji Medical Center ( Site 3426)
-
연락하다:
- Study Coordinator
- 전화번호: +81-79-225-3211
-
-
Iwate
-
Shiwa-gun, Iwate, 일본, 028-3695
- 모병
- Iwate Medical University Hospital ( Site 3428)
-
연락하다:
- Study Coordinator
- 전화번호: +81-19-613-7111
-
-
Kanagawa
-
Kawasaki, Kanagawa, 일본, 216-8511
- 모병
- St. Marianna University Hospital ( Site 3421)
-
연락하다:
- Study Coordinator
- 전화번호: +81-44-977-8111
-
Yokohama, Kanagawa, 일본, 241-8515
- 모병
- Kanagawa Cancer Center ( Site 3408)
-
연락하다:
- Study Coordinator
- 전화번호: +81-45-520-2222
-
Yokohama, Kanagawa, 일본, 221-0855
- 모병
- Yokohama Municipal Citizen's Hospital ( Site 3425)
-
연락하다:
- Study Coordinator
- 전화번호: +81-45-316-4580
-
-
Mie-ken
-
Matsusaka, Mie-ken, 일본, 515-8544
- 모집하지 않고 적극적으로
- Saiseikai Matsusaka Municipal Hospital ( Site 3422)
-
-
Miyagi
-
Sendai, Miyagi, 일본, 981-0914
- 모병
- Sendai Kousei Hospital ( Site 3400)
-
연락하다:
- Study Coordinator
- 전화번호: +81-22-728-8000
-
Sendai, Miyagi, 일본, 980-8574
- 모병
- Tohoku University Hospital ( Site 3424)
-
연락하다:
- Study Coordinator
- 전화번호: +81-22-717-7000
-
-
Osaka
-
Hirakata, Osaka, 일본, 573-1191
- 모병
- Kansai Medical University Hospital ( Site 3412)
-
연락하다:
- Study Coordinator
- 전화번호: +81-72-804-0101
-
Takatsuki, Osaka, 일본, 569-8686
- 모병
- Osaka Medical and Pharmaceutical University Hospital ( Site 3413)
-
연락하다:
- Study Coordinator
- 전화번호: +81-72-683-1221
-
-
Saga-ken
-
Ureshino, Saga-ken, 일본, 843-0393
- 모병
- National Hospital Organization Ureshino Medical Center ( Site 3427)
-
연락하다:
- Study Coordinator
- 전화번호: +81-954-43-1120
-
-
Saitama
-
Niigata, Saitama, 일본, 951-8566
- 모병
- Niigata Cancer Center Hospital ( Site 3409)
-
연락하다:
- Study Coordinator
- 전화번호: +81-25-266-5111
-
-
Shizuoka
-
Suntogun, Shizuoka, 일본, 411-8777
- 모병
- Shizuoka Cancer Center ( Site 3410)
-
연락하다:
- Study Coordinator
- 전화번호: +81-55-989-5222
-
-
Tochigi
-
Shimotsugagun, Tochigi, 일본, 321-0293
- 모병
- Dokkyo Medical University Hospital ( Site 3401)
-
연락하다:
- Study Coordinator
- 전화번호: +81-282-86-1111
-
-
Tokyo
-
Bunkyo, Tokyo, 일본, 113-8677
- 모병
- Tokyo Metropolitan Komagome Hospital ( Site 3405)
-
연락하다:
- Study Coordinator
- 전화번호: +81-3-3823-2101
-
Koto, Tokyo, 일본, 135-8550
- 모병
- Cancer Institute Hospital of JFCR ( Site 3404)
-
연락하다:
- Study Coordinator
- 전화번호: +81-3-3520-0111
-
Shinjuku, Tokyo, 일본, 160-0023
- 모병
- Tokyo Medical University Hospital ( Site 3407)
-
연락하다:
- Study Coordinator
- 전화번호: +81-3-3342-6111
-
Shinjuku, Tokyo, 일본, 162-8655
- 모병
- National Center for Global Health and Medicine ( Site 3406)
-
연락하다:
- Study Coordinator
- 전화번호: +81-3-3202-7181
-
Ōta-ku, Tokyo, 일본, 143-8541
- 모병
- Toho University Omori Medical Center ( Site 3420)
-
연락하다:
- Study Coordinator
- 전화번호: +81-3-3762-4151
-
-
Yamaguchi
-
Ube, Yamaguchi, 일본, 755-0241
- 모병
- National Hospital Organization Yamaguchi Ube Medical Center ( Site 3423)
-
연락하다:
- Study Coordinator
- 전화번호: +81-836-58-2300
-
-
-
-
Anhui
-
Hefei, Anhui, 중국, 230000
- 완전한
- Second Affiliated hospital of Anhui Medical University ( Site 3133)
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, 중국, 100142
- 모집하지 않고 적극적으로
- Beijing Cancer hospital-intrathoratic deparmtment II ( Site 3101)
-
Beijing, Beijing Municipality, 중국, 100730
- 모집하지 않고 적극적으로
- Beijing Peking Union Medical College Hospital-pneumology department ( Site 3100)
-
-
Fujian
-
Fuzhou, Fujian, 중국, 350014
- 모집하지 않고 적극적으로
- Fujian Provincial Cancer Hospital ( Site 3131)
-
Xiamen, Fujian, 중국, 361003
- 모집하지 않고 적극적으로
- The First Affiliated hospital of Xiamen University-Breast Surgery ( Site 3107)
-
-
Guangdong
-
Guangzhou, Guangdong, 중국, 510140
- 모집하지 않고 적극적으로
- The First Affiliated Hospital of Guangzhou Medical University ( Site 3134)
-
Guangzhou, Guangdong, 중국, 510515
- 모집하지 않고 적극적으로
- Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 3108)
-
Zhanjiang, Guangdong, 중국, 524004
- 완전한
- Affiliated Hospital of Guangdong Medical University ( Site 3123)
-
-
Hebei
-
Shijiazhuang, Hebei, 중국, 050000
- 모집하지 않고 적극적으로
- The Second Hospital of Hebei Medical University ( Site 3135)
-
-
Heilongjiang
-
Harbin, Heilongjiang, 중국, 150000
- 모집하지 않고 적극적으로
- Harbin Medical University Cancer Hospital-oncology of department ( Site 3132)
-
-
Henan
-
Zhengzhou, Henan, 중국, 450008
- 모집하지 않고 적극적으로
- Henan Cancer Hospital ( Site 3116)
-
-
Hubei
-
Wuhan, Hubei, 중국, 430000
- 모집하지 않고 적극적으로
- Tongji Hospital Tongji Medical,Science & Technology ( Site 3117)
-
Wuhan, Hubei, 중국, 430079
- 모집하지 않고 적극적으로
- Hubei Cancer Hospital ( Site 3106)
-
Wuhan, Hubei, 중국, 430048
- 모집하지 않고 적극적으로
- Wuhan Union Hospital ( Site 3130)
-
Xiangyang, Hubei, 중국, 441106
- 모집하지 않고 적극적으로
- Xiangyang Central Hospital-oncology department ( Site 3136)
-
-
Hunan
-
Changsha, Hunan, 중국, 410011
- 모집하지 않고 적극적으로
- The Second Xiangya Hospital of Central South University ( Site 3138)
-
-
Jiangsu
-
Wuxi, Jiangsu, 중국, 214122
- 모집하지 않고 적극적으로
- Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3113)
-
Xuzhou, Jiangsu, 중국, 221002
- 완전한
- The Affiliated Hospital of Xuzhou Medical College ( Site 3112)
-
-
Jiangxi
-
Nanchang, Jiangxi, 중국, 330006
- 모집하지 않고 적극적으로
- The Second Affiliated Hospital of Nanchang University-Oncology Department ( Site 3121)
-
Nanchang, Jiangxi, 중국, 330029
- 모집하지 않고 적극적으로
- Jiangxi Provincial Cancer Hospital ( Site 3143)
-
Nanchang, Jiangxi, 중국, 330006
- 모집하지 않고 적극적으로
- The First Affiliated Hospital of Nanchang University-Respiratory Medicine Department ( Site 3127)
-
-
Jilin
-
Changchun, Jilin, 중국, 130000
- 모집하지 않고 적극적으로
- Jilin Province Tumor Hospital-oncology department ( Site 3126)
-
-
Shandong
-
Jinan, Shandong, 중국, 250117
- 모집하지 않고 적극적으로
- Shandong Cancer Hospital ( Site 3119)
-
Jinan, Shandong, 중국, 250013
- 모집하지 않고 적극적으로
- Jinan Central Hospital-oncology department ( Site 3122)
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, 중국, 200082
- 모집하지 않고 적극적으로
- Shanghai Changhai Hospital ( Site 3125)
-
-
Sichuan
-
Chengdu, Sichuan, 중국, 610042
- 완전한
- Sichuan Cancer hospital. ( Site 3105)
-
Chengdu, Sichuan, 중국, 610041
- 모집하지 않고 적극적으로
- West China Hospital, Sichuan University ( Site 3124)
-
Neijiang, Sichuan, 중국, 641099
- 모집하지 않고 적극적으로
- The Second People's Hospital of Neijiang ( Site 3140)
-
-
Yunnan
-
Kunming, Yunnan, 중국, 650107
- 모집하지 않고 적극적으로
- Yunnan Province Cancer Hospital ( Site 3139)
-
-
Zhejiang
-
Hangzhou, Zhejiang, 중국, 310003
- 모집하지 않고 적극적으로
- The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115)
-
Hangzhou, Zhejiang, 중국, 310016
- 모집하지 않고 적극적으로
- Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3111)
-
Taizhou, Zhejiang, 중국, 317000
- 모집하지 않고 적극적으로
- Taizhou Hospital of Zhejiang Province-Respiratory ( Site 3114)
-
-
-
-
-
Olomouc, 체코, 779 00
- 모병
- Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberkulozy ( Site 1102)
-
연락하다:
- Study Coordinator
- 전화번호: +420 588 443 666
-
-
Ostrava Mesto
-
Ostrava, Ostrava Mesto, 체코, 703 00
- 모병
- Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni oddeleni ( Site 1103)
-
연락하다:
- Study Coordinator
- 전화번호: +420 595 633 400
-
-
Pardubice Region
-
Pardubice, Pardubice Region, 체코, 532 03
- 모병
- Multiscan-Onkologicke a radiologicke centrum Multiscan Pardubice ( Site 1105)
-
연락하다:
- Study Coordinator
- 전화번호: +420466016436
-
-
Praha 2
-
Prague, Praha 2, 체코, 128 08
- 모병
- Vseobecna fakultni nemocnice v Praze-Onkologicka klinika ( Site 1106)
-
연락하다:
- Study Coordinator
- 전화번호: +420224962143
-
-
-
-
-
Antofagasta, 칠레, 1263521
- 모병
- Bradford Hill Norte ( Site 0516)
-
연락하다:
- Study Coordinator
- 전화번호: 56442023631
-
-
Maule Region
-
Talca, Maule Region, 칠레, 3465584
- 모병
- Clinica Universidad Catolica del Maule-Oncology ( Site 0501)
-
연락하다:
- Study Coordinator
- 전화번호: 56947532700
-
-
Region M. de Santiago
-
Santiago, Region M. de Santiago, 칠레, 7500713
- 모병
- Orlandi Oncologia-Oncology ( Site 0504)
-
연락하다:
- Study Coordinator
- 전화번호: 56226057491
-
Santiago, Region M. de Santiago, 칠레, 7500921
- 모병
- FALP-UIDO ( Site 0509)
-
연락하다:
- Study Coordinator
- 전화번호: 56224205098
-
Santiago, Region M. de Santiago, 칠레, 8420383
- 모병
- Bradfordhill-Clinical Area ( Site 0507)
-
연락하다:
- Study Coordinator
- 전화번호: 56229490970
-
-
-
-
Ontario
-
Brampton, Ontario, 캐나다, L6R 3J7
- 모병
- William Osler Health System ( Site 0203)
-
연락하다:
- Study Coordinator
- 전화번호: 905-494-2120
-
Mississauga, Ontario, 캐나다, L5M 2N1
- 모병
- Trillium Health Partners - Credit Valley Hospital ( Site 0202)
-
연락하다:
- Study Coordinator
- 전화번호: 905-813-1100x4299
-
-
Quebec
-
Montreal, Quebec, 캐나다, H4A 3J1
- 완전한
- McGill University Health Centre ( Site 0200)
-
-
-
-
Bogota D.C.
-
Bogotá, Bogota D.C., 콜롬비아, 110131
- 모병
- FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0600)
-
연락하다:
- Study Coordinator
- 전화번호: 3219198898
-
-
Departamento de Córdoba
-
Montería, Departamento de Córdoba, 콜롬비아, 230002
- 모병
- IMAT S.A.S ( Site 0602)
-
연락하다:
- Study Coordinator
- 전화번호: +57 (3135342052)
-
-
Risaralda Department
-
Pereira, Risaralda Department, 콜롬비아, 660001
- 모병
- Oncologos del Occidente ( Site 0603)
-
연락하다:
- Study Coordinator
- 전화번호: 573002558656
-
-
-
-
Bangkok
-
Bangkok, Bangkok, 태국, 10700
- 모병
- Faculty of Medicine Siriraj Hospital ( Site 4000)
-
연락하다:
- Study Coordinator
- 전화번호: +6624194489
-
Pathumwan, Bangkok, 태국, 10330
- 모병
- Chulalongkorn University ( Site 4003)
-
연락하다:
- Study Coordinator
- 전화번호: +6622564533
-
-
Chiang Mai
-
Muang, Chiang Mai, 태국, 50200
- 모병
- Maharaj Nakorn Chiang Mai Hospital ( Site 4001)
-
연락하다:
- Study Coordinator
- 전화번호: +6653935480
-
-
-
-
-
Adana, 터키 (Türkiye), 01140
- 모병
- Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2507)
-
연락하다:
- Study Coordinator
- 전화번호: +905056166338
-
Ankara, 터키 (Türkiye), 06200
- 모병
- Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi-oncology ( Site 2506)
-
연락하다:
- Study Coordinator
- 전화번호: +903123360909
-
Ankara, 터키 (Türkiye), 06230
- 모병
- Hacettepe Universite Hastaneleri-oncology hospital ( Site 2501)
-
연락하다:
- Study Coordinator
- 전화번호: +903123052841
-
Ankara, 터키 (Türkiye), 06520
- 모병
- Memorial Ankara Hastanesi-Medical Oncology ( Site 2505)
-
연락하다:
- Study Coordinator
- 전화번호: +90 5067521275
-
Ankara, 터키 (Türkiye), 06800
- 모병
- Ankara Bilkent Şehir Hastanesi ( Site 2500)
-
연락하다:
- Study Coordinator
- 전화번호: +903125526000
-
Denizli, 터키 (Türkiye), 20070
- 모병
- Pamukkale University Medical Faculty, Fahri Goksin Oncology Centre-Oncolgyy-Hematology ( Site 2510)
-
연락하다:
- Study Coordinator
- 전화번호: 0090 258 296 5142
-
Istanbul, 터키 (Türkiye), 34722
- 모병
- TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2502)
-
연락하다:
- Study Coordinator
- 전화번호: +902166065200
-
Samsun, 터키 (Türkiye), 55139
- 모병
- Ondokuz Mayıs Universitesi ( Site 2509)
-
연락하다:
- Study Coordinator
- 전화번호: +90 362 312 1919
-
-
Istanbul
-
Stanbul, Istanbul, 터키 (Türkiye), 34214
- 모병
- Medipol Mega Universite Hastanesi-oncology ( Site 2508)
-
연락하다:
- Study Coordinator
- 전화번호: +90 5325280486
-
-
Kayseri
-
Talas, Kayseri, 터키 (Türkiye), 38039
- 모병
- Erciyes University ( Site 2511)
-
연락하다:
- Study Coordinator
- 전화번호: +90 207 666 6270
-
-
İzmir
-
Bornova, İzmir, 터키 (Türkiye), 35100
- 모병
- Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2503)
-
연락하다:
- Study Coordinator
- 전화번호: 0090 232 390 43 34
-
-
-
-
-
Lima, 페루, 15038
- 모병
- INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0850)
-
연락하다:
- Study Coordinator
- 전화번호: +51940238282
-
Lima, 페루, Lima 31
- 모병
- Hospital Cayetano Heredia-Oncology ( Site 0855)
-
연락하다:
- Study Coordinator
- 전화번호: +51 986981097
-
Lima, 페루, 15047
- 모병
- Instituto Neuro Cardiovascular de las Americas ( Site 0856)
-
연락하다:
- Study Coordinator
- 전화번호: +51991366612
-
Lima, 페루, 15036
- 모집하지 않고 적극적으로
- IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 0851)
-
-
Ariqipa
-
Arequipa, Ariqipa, 페루, 15036
- 모집하지 않고 적극적으로
- Clinica Vallesur - AUNA ( Site 0854)
-
-
Muni Metro de Lima
-
Surquillo, Muni Metro de Lima, 페루, 15038
- 모병
- Detecta Clínica ( Site 0853)
-
연락하다:
- Study Coordinator
- 전화번호: +51992783190
-
-
-
-
-
Lisbon, 포르투갈, 1350-352
- 모병
- Hospital CUF - Tejo ( Site 2100)
-
연락하다:
- Study Coordinator
- 전화번호: +351213926100
-
-
Lisbon District
-
Lisbon, Lisbon District, 포르투갈, 1099-023
- 모병
- Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 2104)
-
연락하다:
- Study Coordinator
- 전화번호: 00351217229800
-
Lisbon, Lisbon District, 포르투갈, 1769-001
- 모병
- Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 2101)
-
연락하다:
- Study Coordinator
- 전화번호: 00351217805000
-
-
Madeira
-
Funchal, Madeira, 포르투갈, 9004-514
- 모병
- Hospital Dr. Nélio Mendonça ( Site 2105)
-
연락하다:
- Study Coordinator
- 전화번호: +351291705600
-
-
Porto District
-
Vila Nova de Gaia, Porto District, 포르투갈, 4434-502
- 완전한
- Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 2103)
-
-
-
-
Kuyavian-Pomeranian Voivodeship
-
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 폴란드, 85-796
- 모병
- Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 2003)
-
연락하다:
- Study Coordinator
- 전화번호: 523743589
-
Grudziądz, Kuyavian-Pomeranian Voivodeship, 폴란드, 86-300
- 완전한
- Regionalny Szpital Specjalistyczny im. dr. Władyslawa Biegańskiego ( Site 2013)
-
Torun, Kuyavian-Pomeranian Voivodeship, 폴란드, 87-100
- 완전한
- Wojewodzki Szpital Zespolony im Ludwika Rydygiera w Toruniu ( Site 2016)
-
-
Lesser Poland Voivodeship
-
Krakow, Lesser Poland Voivodeship, 폴란드, 31-826
- 모병
- Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 2015)
-
연락하다:
- Study Coordinator
- 전화번호: 12 646 82 85
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, 폴란드, 02-781
- 모병
- Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2000)
-
연락하다:
- Study Coordinator
- 전화번호: +48225462248
-
Warsaw, Masovian Voivodeship, 폴란드, 01-138
- 모병
- Instytut Gruzlicy i Chorob Pluc w Warszawie ( Site 2011)
-
연락하다:
- Study Coordinator
- 전화번호: 00 48 22 431 22 79
-
-
Podkarpackie Voivodeship
-
Przemyśl, Podkarpackie Voivodeship, 폴란드, 37-700
- 모병
- Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2001)
-
연락하다:
- Study Coordinator
- 전화번호: 16 677 55 10
-
-
Warmian-Masurian Voivodeship
-
Olsztyn, Warmian-Masurian Voivodeship, 폴란드, 10-357
- 모병
- Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 2018)
-
연락하다:
- Study Coordinator
- 전화번호: +48895322978
-
-
Łódź Voivodeship
-
Lodz, Łódź Voivodeship, 폴란드, 90-549
- 완전한
- SPZOZ Uniwersytecki Szpital Kliniczny Im. Wojskowej Akademii Medycznej UM W Łodzi Centralny Szpital ( Site 2012)
-
-
-
-
Bouches-du-Rhone
-
Marseille, Bouches-du-Rhone, 프랑스, 13008
- 모병
- Hôpital Saint Joseph-ONCOLOGY ( Site 1308)
-
연락하다:
- Study Coordinator
- 전화번호: +33491806500
-
-
Herault
-
Montpellier, Herault, 프랑스, 34298
- 모병
- Institut Régional du Cancer Montpellier-Medical Oncology ( Site 1309)
-
연락하다:
- Study Coordinator
- 전화번호: +33467613100
-
-
Limousin
-
Limoges, Limousin, 프랑스, 87042
- 모병
- Centre Hospitalier Universitaire de Limoges - Hôpital Dupuyt-Unité d'oncologie thoracique et cutané ( Site 1303)
-
연락하다:
- Study Coordinator
- 전화번호: +33555056892
-
-
Meurthe-et-Moselle
-
Nancy, Meurthe-et-Moselle, 프랑스, 54000
- 모병
- Centre d'Oncologie de Gentilly ( Site 1301)
-
연락하다:
- Study Coordinator
- 전화번호: 0033355685518
-
-
Pyrenees-Atlantiques
-
Bayonne, Pyrenees-Atlantiques, 프랑스, 64109
- 모병
- Centre Hospitalier de la Cote Basque ( Site 1300)
-
연락하다:
- Study Coordinator
- 전화번호: 33559443172
-
-
Rhone
-
Villefranche-sur-Saône, Rhone, 프랑스, 69655
- 모병
- L HOPITAL NORD OUEST ( Site 1310)
-
연락하다:
- Study Coordinator
- 전화번호: +33642346915
-
-
Somme
-
Amiens, Somme, 프랑스, 80000
- 모병
- Clinique de l'Europe-Service de pneumologie ( Site 1304)
-
연락하다:
- Study Coordinator
- 전화번호: 00 33 3 23 06 72 24
-
-
Vienne
-
Poitiers, Vienne, 프랑스, 86021
- 모병
- Centre Hospitalier Universitaire de Poitiers-Pôle régional de cancérologie ( Site 1305)
-
연락하다:
- Study Coordinator
- 전화번호: 00330516604212
-
-
-
-
New South Wales
-
Port Macquarie, New South Wales, 호주, 2444
- 모병
- Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 3002)
-
연락하다:
- Study Coordinator
- 전화번호: +61265801820
-
Westmead, New South Wales, 호주, 2145
- 모병
- Westmead Hospital ( Site 3000)
-
연락하다:
- Study Coordinator
- 전화번호: +61247343500
-
-
Victoria
-
Ballarat Central, Victoria, 호주, 3350
- 완전한
- Grampians Health-Medical Oncology ( Site 3001)
-
Epping, Victoria, 호주, 3076
- 모병
- Northern Hospital ( Site 3003)
-
연락하다:
- Study Coordinator
- 전화번호: +61384058715
-
Frankston, Victoria, 호주, 3199
- 모병
- Peninsula University Hospital ( Site 3004)
-
연락하다:
- Study Coordinator
- 전화번호: +61397847175
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
Histologically or cytologically confirmed diagnosis of squamous or nonsquamous NSCLC
- Confirmation that epidermal growth factor receptor- (EGFR-), anaplastic lymphoma kinase- (ALK-), or proto-oncogene tyrosine-protein kinase ROS (ROS1-) directed therapy is not indicated as primary therapy
- Provided tumor tissue that demonstrates programmed cell death ligand 1 (PD-L1) expression in ≥50% of tumor cells as assessed by an immunohistochemistry (IHC) central laboratory
- An Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 assessed within 7 days before randomization.
- A life expectancy of at least 3 months.
- Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on antiretroviral therapy (ART)
Exclusion Criteria:
- Diagnosis of small cell lung cancer or, for mixed tumors, presence of small cell elements.
- Has Grade ≥2 peripheral neuropathy.
- History of documented severe dry eye syndrome, severe Meibomian gland disease and/or blepharitis, or severe corneal disease that prevents/delays corneal healing.
- Has active inflammatory bowel disease requiring immunosuppressive medication or previous clear history of inflammatory bowel disease (eg, Crohn's disease, ulcerative colitis, or chronic diarrhea).
- Has uncontrolled, significant cardiovascular disease or cerebrovascular disease within the 6 months preceding study intervention.
- Received prior systemic anticancer therapy for their metastatic NSCLC.
- Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent, or with an agent directed to another stimulatory or coinhibitory T-cell receptor Note: Prior treatment with an anti-PD-1, anti-PD- L1, or anti-PD-L2 agent in the neoadjuvant or adjuvant setting for nonmetastatic resectable NSCLC is allowed as long as therapy was completed at least 12 months before diagnosis of metastatic NSCLC.
- Received prior systemic anticancer therapy including investigational agents within 4 weeks before randomization.
- Received radiation therapy to the lung that is >30 Gy within 6 months of start of study intervention.
- Received prior radiotherapy within 2 weeks of start of study intervention, or radiation-related toxicities, requiring corticosteroids.
- Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention. Administration of killed vaccines are allowed.
- Diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy
- Known additional malignancy that is progressing or has required active treatment within the past 3 years.
- Known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
- Known intolerance to sacituzumab tirumotecan or pembrolizumab and/or any of their excipients; for pembrolizumab, severe hypersensitivity (≥Grade 3) is exclusionary.
- Known hypersensitivity to sacituzumab tirumotecan or other biologic therapy.
- Active autoimmune disease that has required systemic treatment in the past 2 years.
- History of (noninfectious) pneumonitis/interstitial lung disease (ILD) that required steroids or has current pneumonitis/ILD.
- Active infection requiring systemic therapy
- Concurrent active Hepatitis B and Hepatitis C virus infection.
- Human immunodeficiency virus (HIV)-infected participants with a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease.
- History of allogeneic tissue/solid organ transplant.
- Requires treatment with a strong inhibitor or inducer of Cytochrome P450 3A4 (CYP3A4) at least 14 days before the first dose of study intervention and throughout the study.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Pembrolizumab + Sacituzumab tirumotecan
Participants receive sacituzumab tirumotecan via intravenous (IV) infusion on Days 1, 15 and 29 of each 6-week cycle + 400 mg Pembrolizumab every 6 weeks (q6w) via IV infusion on Day 1 of each 6-week cycle for 18 cycles. Additionally, participants receive diphenhydramine (or equivalent), an H2 antagonist of investigator's choice, acetaminophen (or equivalent), and dexamethasone (or equivalent) per each drug's product label prior to the first 4 infusions of sacituzumab tirumotecan. At subsequent infusions, the H2 antagonist and dexamethasone are optional, at the discretion of the investigator. |
IV infusion
다른 이름들:
IV infusion
다른 이름들:
Participants are allowed to take supportive care measures at the discretion of the investigator. Prophylactic supportive care measures may include but are not limited to antiemetic agents, antidiarrheal agents, granulocyte and erythroid growth factors, and blood transfusions |
|
활성 비교기: Pembrolizumab
Participants receive 400 mg Pembrolizumab via IV infusion q6w on Day 1 of each 6-week cycle for 18 cycles |
IV infusion
다른 이름들:
Participants are allowed to take supportive care measures at the discretion of the investigator. Prophylactic supportive care measures may include but are not limited to antiemetic agents, antidiarrheal agents, granulocyte and erythroid growth factors, and blood transfusions |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Overall Survival (OS)
기간: Up to approximately 49 months
|
OS is defined as the time from randomization to death from any cause. |
Up to approximately 49 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Progression free survival (PFS)
기간: Up to approximately 49 months
|
PFS is defined as the time from randomization to the first documented disease progression per RECIST 1.1 based on BICR or death due to any cause, whichever occurs first |
Up to approximately 49 months
|
|
Objective Response (OR)
기간: Up to approximately 49 months
|
The OR is defined as a confirmed complete response (CR) or partial response (PR) per RECIST 1.1 as assessed by BICR. |
Up to approximately 49 months
|
|
Duration of Response (DOR)
기간: Up to approximately 49 months
|
For participants who demonstrate confirmed CR or PR per RECIST 1.1 as assessed by BICR, duration of response is defined as the time from the first documented evidence of CR or PR until disease progression or death due to any cause, whichever occurs first. |
Up to approximately 49 months
|
|
Change from Baseline in Global Health Status/Quality of Life (QOL) [European Organisation for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30) 29 Items and 30] Score
기간: Baseline and up to approximately 77 months
|
Change from baseline in the score of EORTC QLQ-C30 Items 29 and 30 will be presented. The EORTC-QLQ-C30 is a 30-item questionnaire developed to assess the quality of life of cancer patients. Participant responses to Items 29 and 30 ("How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?") are scored on a 7-point scale (1=Very Poor to 7=Excellent). A higher score indicates a better overall outcome. |
Baseline and up to approximately 77 months
|
|
Change From Baseline in Dyspnea (EORTC QLQ-C30 Item 8) Score
기간: Baseline and up to approximately 77 months
|
Change from baseline in the score of EORTC QLQ-C30 Item 8 will be presented. The EORTC QLQ-C30 is a cancer specific health-related quality-of life (QoL) questionnaire. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates a worse level of dyspnea. |
Baseline and up to approximately 77 months
|
|
Change From Baseline in Cough (EORTC QLQ-LC13 Item 31) Score
기간: Baseline and up to approximately 77 months
|
Change from baseline in the score of EORTC QLQ-C13 Item 31 will be presented. The EORTC QLQ-C13 is a lung cancer specific health-related quality-of life (QoL) questionnaire. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates more frequent coughing. |
Baseline and up to approximately 77 months
|
|
Change From Baseline in Chest Pain (EORTC QLQ-LC13 item 40) Score
기간: Baseline and up to approximately 77 months
|
The EORTC QLQ-LC13 is a lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant responses to the question "Have you had pain in your chest?" are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The change from baseline in chest pain (EORTC QLQ-LC13 Item 40) score will be presented. A lower score indicates a better outcome. |
Baseline and up to approximately 77 months
|
|
Time to Deterioration (TTD) Based on Change From Baseline in Global Health Status (GHS)/ QOL Score (EORTC QLQ-C30 Item 29 and 30)
기간: Up to approximately 77 months
|
The TTD in GHS/QOL score (EORTC QLQ-C30 Items 29 and 30) will be presented. Participant responses to Items 29 and 30 ("How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?") are scored on a 7-point scale (1=Very Poor to 7=Excellent). A higher score indicates a better overall outcome. TTD as assessed based on a negative change (decrease in score) from Baseline in GHS/QOL score. A longer TTD indicates a better outcome. |
Up to approximately 77 months
|
|
Time to Deterioration (TTD) Based on Change From Baseline in Dyspnea Score (EORTC QLQ-C30 Item 8)
기간: Up to approximately 77 months
|
The TTD in Dyspnea score (EORTC QLQ-C30 Item 8) will be presented. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates a worse level of dyspnea. TTD is assessed based on the time to a negative change (increase in score) from baseline. A longer TTD indicates a better outcome. |
Up to approximately 77 months
|
|
Time to Deterioration (TTD) Based on Change From Baseline in Cough Score (EORTC QLQ-LC13 Item 31).
기간: Up to approximately 77 months
|
The TTD in Cough score (EORTC QLQ-LC13 Item 31) will be presented. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates more frequent coughing. TTD is assessed based on the time to a negative change (increase in score) from baseline. A longer TTD indicates a better outcome. |
Up to approximately 77 months
|
|
Time to Deterioration (TTD) Based on Change From Baseline in Chest Pain Score (EORTC QLQ-LC13 Item 40)
기간: Up to approximately 77 months
|
The TTD in Chest Pain score (EORTC QLQ-LC13 Item 40) will be presented. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates a worse level of chest pain. TTD is assessed based on the time to a negative change (increase in score) from baseline. A longer TTD indicates a better outcome. |
Up to approximately 77 months
|
|
Percentage of Participants That Experience at Least 1 Adverse Event
기간: Up to approximately 77 months
|
An AE is any untoward medical occurrence in a participant, temporally associated with the use of study treatment, whether or not considered related to the study treatment. The percentage of participants who experience an AE will be presented. |
Up to approximately 77 months
|
|
Percentage of Participants Who Discontinue Study Treatment Due to an AE
기간: Up to approximately 77 months
|
The percentage of participants who discontinue study treatment due to an AE will be presented. |
Up to approximately 77 months
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Medical Director, Merck Sharp & Dohme LLC
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 2870-007
- MK-2870-007 (기타 식별자: MSD)
- 2023-503376-24-00 (기타 식별자: EU CT)
- jRCT2051240089 (레지스트리 식별자: Japan Registry of Clinical Trials (jRCT))
- U1111-1287-1395 (레지스트리 식별자: UTN)
- 2023 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .